{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:12:00Z","timestamp":1772172720236,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008464","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000}}],"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003185","name":"Fraunhofer-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003185","name":"Fraunhofer-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Elucidating the causal mechanisms responsible for disease can reveal potential therapeutic targets for pharmacological intervention and, accordingly, guide drug repositioning and discovery. In essence, the topology of a network can reveal the impact a drug candidate may have on a given biological state, leading the way for enhanced disease characterization and the design of advanced therapies. Network-based approaches, in particular, are highly suited for these purposes as they hold the capacity to identify the molecular mechanisms underlying disease. Here, we present drug2ways, a novel methodology that leverages multimodal causal networks for predicting drug candidates. Drug2ways implements an efficient algorithm which reasons over causal paths in large-scale biological networks to propose drug candidates for a given disease. We validate our approach using clinical trial information and demonstrate how drug2ways can be used for multiple applications to identify: i) single-target drug candidates, ii) candidates with polypharmacological properties that can optimize multiple targets, and iii) candidates for combination therapy. Finally, we make drug2ways available to the scientific community as a Python package that enables conducting these applications on multiple standard network formats.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1008464","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T14:35:12Z","timestamp":1606919712000},"page":"e1008464","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Drug2ways: Reasoning over causal paths in biological networks for drug discovery"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-7890","authenticated-orcid":true,"given":"Daniel","family":"Rivas-Barragan","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9858-3755","authenticated-orcid":true,"given":"Sarah","family":"Mubeen","sequence":"additional","affiliation":[]},{"given":"Francesc","family":"Guim Bernat","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Hofmann-Apitius","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2046-6145","authenticated-orcid":true,"given":"Daniel","family":"Domingo-Fern\u00e1ndez","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"issue":"1","key":"pcbi.1008464.ref001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-0381-4-10","article-title":"Using graph theory to analyze biological networks","volume":"4","author":"GA Pavlopoulos","year":"2011","journal-title":"BioData mining"},{"key":"pcbi.1008464.ref002","doi-asserted-by":"crossref","unstructured":"Naldi A, Thieffry D, Chaouiya C. Decision diagrams for the representation and analysis of logical models of genetic networks. Proceedings of the 2007 international conference on International Conference on Computational Methods in Systems Biology. Berlin, Heidelberg: Springer-Verlag; 2007:233\u2013247. 2007. https:\/\/doi.org\/10.1007\/978-3-540-75140-3_16.","DOI":"10.1007\/978-3-540-75140-3_16"},{"issue":"3","key":"pcbi.1008464.ref003","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0022-5193(69)90015-0","article-title":"Metabolic stability and epigenesis in randomly constructed genetic nets","volume":"22","author":"SA Kauffman","year":"1969","journal-title":"J Theor Biol"},{"issue":"2","key":"pcbi.1008464.ref004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/bioinformatics\/18.2.261","article-title":"Probabilistic Boolean networks: a rule-based uncertainty model for gene regulatory networks","volume":"18","author":"I Shmulevich","year":"2002","journal-title":"Bioinformatics"},{"issue":"4","key":"pcbi.1008464.ref005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nmeth.3773","article-title":"Inferring causal molecular networks: empirical assessment through a community-based effort","volume":"13","author":"SM Hill","year":"2016","journal-title":"Nat Methods"},{"key":"pcbi.1008464.ref006","article-title":"PAIRS: Prediction of Activation\/Inhibition Regulation Signaling Pathway","author":"T Wang","year":"2017","journal-title":"Computational intelligence and neuroscience, 2017"},{"issue":"1","key":"pcbi.1008464.ref007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12918-018-0535-4","article-title":"Annotating activation\/inhibition relationships to protein-protein interactions using gene ontology relations","volume":"12","author":"S Yim","year":"2018","journal-title":"BMC Syst Biol"},{"issue":"2","key":"pcbi.1008464.ref008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/bib\/bby025","article-title":"Navigating the disease landscape: knowledge representations for contextualizing molecular signatures","volume":"20","author":"M Saqi","year":"2019","journal-title":"Brief Bioinform"},{"issue":"27","key":"pcbi.1008464.ref009","doi-asserted-by":"crossref","first-page":"E6375","DOI":"10.1073\/pnas.1720589115","article-title":"Predicting perturbation patterns from the topology of biological networks","volume":"115","author":"M Santolini","year":"2018","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"pcbi.1008464.ref010","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, Cytoscape and EnrichmentMap","volume":"14","author":"J Reimand","year":"2019","journal-title":"Nat Protoc"},{"issue":"3","key":"pcbi.1008464.ref011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","article-title":"Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review","volume":"138","author":"P Csermely","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"1","key":"pcbi.1008464.ref012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"S Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"pcbi.1008464.ref013","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrd2826","article-title":"A network view of disease and compound screening","volume":"8","author":"EE Schadt","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"pcbi.1008464.ref014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"A Barab\u00e1si","year":"2011","journal-title":"Nat Rev Genet"},{"key":"pcbi.1008464.ref015","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Y\u0131ld\u0131r\u0131m","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"1","key":"pcbi.1008464.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09692-y","article-title":"Network-based prediction of drug combinations","volume":"10","author":"F Cheng","year":"2019","journal-title":"Nat Commun"},{"issue":"19","key":"pcbi.1008464.ref017","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery: miniperspective","volume":"57","author":"A Anighoro","year":"2014","journal-title":"J Med Chem"},{"issue":"14","key":"pcbi.1008464.ref018","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1073\/pnas.1820799116","article-title":"From single drug targets to synergistic network pharmacology in ischemic stroke","volume":"116","author":"AI Casas","year":"2019","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"pcbi.1008464.ref019","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"B Al-Lazikani","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"2","key":"pcbi.1008464.ref020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/0008-5472.CAN-16-0097","article-title":"Quantification of pathway cross-talk reveals novel synergistic drug combinations for breast cancer","volume":"77","author":"S Jaeger","year":"2017","journal-title":"Cancer Res"},{"issue":"5","key":"pcbi.1008464.ref021","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu115","article-title":"Combination therapy with cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"18","author":"S Matsunaga","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"pcbi.1008464.ref022","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","article-title":"Network-based in silico drug efficacy screening","volume":"7","author":"E Guney","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"pcbi.1008464.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13208-z","article-title":"A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome","volume":"10","author":"K Misselbeck","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"pcbi.1008464.ref024","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/etc.4124","article-title":"Adverse outcome pathway networks II: network analytics","volume":"37","author":"DL Villeneuve","year":"2018","journal-title":"Environ Toxicol Chem"},{"issue":"1","key":"pcbi.1008464.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2043-9113-2-1","article-title":"A network flow approach to predict drug targets from microarray data, disease genes and interactome network-case study on prostate cancer","volume":"2","author":"SH Yeh","year":"2012","journal-title":"Journal of clinical bioinformatics"},{"issue":"D1","key":"pcbi.1008464.ref026","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"J Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1008464.ref027","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcf.2018.05.013","article-title":"AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations","volume":"18","author":"RJ Darrah","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"3","key":"pcbi.1008464.ref028","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.201905-0990OC","article-title":"Losartan rescues inflammation-related mucociliary dysfunction in relevant models of cystic fibrosis","volume":"201","author":"MD Kim","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pcbi.1008464.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15916","article-title":"CDK4\/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers","volume":"8","author":"S Vijayaraghavan","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"pcbi.1008464.ref030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1758834016677961","article-title":"Progress with palbociclib in breast cancer: latest evidence and clinical considerations","volume":"9","author":"A Rocca","year":"2017","journal-title":"Therapeutic advances in medical oncology"},{"issue":"26","key":"pcbi.1008464.ref031","doi-asserted-by":"crossref","first-page":"39595","DOI":"10.18632\/oncotarget.9153","article-title":"Efficacy of the combination of MEK and CDK4\/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models","volume":"7","author":"MS Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"pcbi.1008464.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-6626-9","article-title":"Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report","volume":"20","author":"Y Adachi","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"pcbi.1008464.ref033","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1158\/1078-0432.CCR-15-0589","article-title":"Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non\u2013Small Cell Lung Cancers In Vitro and In Vivo","volume":"22","author":"Z Tao","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"8","key":"pcbi.1008464.ref034","doi-asserted-by":"crossref","first-page":"12576","DOI":"10.18632\/oncotarget.14990","article-title":"The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma","volume":"8","author":"C. M Simbulan-Rosenthal","year":"2017","journal-title":"Oncotarget"},{"key":"pcbi.1008464.ref035","unstructured":"Hagberg A. A, Schult DA, and Swart PJ. (2008). Exploring network structure, dynamics, and function using NetworkX. Proceedings of the 7th Python in Science Conference (SciPy2008), 11\u201315."},{"issue":"4","key":"pcbi.1008464.ref036","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1017\/nws.2016.20","article-title":"NetworKit: A tool suite for large-scale complex network analysis","volume":"4","author":"CL Staudt","year":"2016","journal-title":"Network Science"},{"issue":"9","key":"pcbi.1008464.ref037","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrg.2017.38","article-title":"Network propagation: a universal amplifier of genetic associations","volume":"18","author":"L Cowen","year":"2017","journal-title":"Nat Rev Genet"},{"issue":"5","key":"pcbi.1008464.ref038","doi-asserted-by":"crossref","first-page":"giz054","DOI":"10.1093\/gigascience\/giz054","article-title":"Software engineering for scientific big data analysis","volume":"8","author":"BA Gr\u00fcning","year":"2019","journal-title":"GigaScience"},{"key":"pcbi.1008464.ref039","first-page":"btaa274","article-title":"OpenBioLink: A resource and benchmarking framework for large-scale biomedical link prediction","author":"A Breit","year":"2020","journal-title":"Bioinformatics"},{"key":"pcbi.1008464.ref040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12859-019-2863-9","article-title":"PathMe: Merging and exploring mechanistic pathway knowledge","volume":"20","author":"D Domingo-Fern\u00e1ndez","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"pcbi.1008464.ref041","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"M Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pcbi.1008464.ref042","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"B Jassal","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pcbi.1008464.ref043","doi-asserted-by":"crossref","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","article-title":"WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research","volume":"46","author":"DN Slenter","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pcbi.1008464.ref044","doi-asserted-by":"crossref","first-page":"D529","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"R Oughtred","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pcbi.1008464.ref045","doi-asserted-by":"crossref","first-page":"D358","DOI":"10.1093\/nar\/gkt1115","article-title":"The MIntAct project\u2014IntAct as a common curation platform for 11 molecular interaction databases","volume":"42","author":"S Orchard","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pcbi.1008464.ref046","first-page":"D489","article-title":"Pathway Commons 2019 Update: integration, analysis and exploration of pathway data","volume":"48","author":"I Rodchenkov","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"pcbi.1008464.ref047","first-page":"D1035","article-title":"DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs","volume":"39","author":"C Knox","year":"2010","journal-title":"Nucleic acids research"},{"key":"pcbi.1008464.ref048","article-title":"Network medicine framework for identifying drug repurposing opportunities for COVID-19","author":"DM Gysi","year":"2020","journal-title":"arXiv"},{"issue":"1","key":"pcbi.1008464.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-42806-6","article-title":"Drug prioritization using the semantic properties of a knowledge graph","volume":"9","author":"TB Malas","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1008464.ref050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/bib\/bbr008","article-title":"Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them)","volume":"13","author":"D Berrar","year":"2012","journal-title":"Brief Bioinform"},{"key":"pcbi.1008464.ref051","doi-asserted-by":"crossref","unstructured":"Hanhij\u00e4rvi S, Garriga GC, Puolam\u00e4ki K. Randomization techniques for graphs. In Proceedings of the 2009 SIAM International Conference on Data Mining (pp. 780\u2013791). 2009. https:\/\/doi.org\/10.1137\/1.9781611972795.67.","DOI":"10.1137\/1.9781611972795.67"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008464","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T13:59:21Z","timestamp":1607954361000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008464"}},"subtitle":[],"editor":[{"given":"James R.","family":"Faeder","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008464","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.07.138388","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]}}}